Compare Unichem Lab with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB CIPLA UNICHEM LAB/
CIPLA
 
P/E (TTM) x -102.4 23.9 - View Chart
P/BV x 0.6 2.4 23.1% View Chart
Dividend Yield % 2.5 0.7 373.3%  

Financials

 UNICHEM LAB   CIPLA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
CIPLA
Mar-19
UNICHEM LAB/
CIPLA
5-Yr Chart
Click to enlarge
High Rs292678 43.1%   
Low Rs182484 37.6%   
Sales per share (Unadj.) Rs167.7198.2 84.6%  
Earnings per share (Unadj.) Rs-3.618.5 -19.6%  
Cash flow per share (Unadj.) Rs5.935.0 17.0%  
Dividends per share (Unadj.) Rs4.003.00 133.3%  
Dividend yield (eoy) %1.70.5 326.8%  
Book value per share (Unadj.) Rs372.3186.3 199.8%  
Shares outstanding (eoy) m70.38805.70 8.7%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x1.42.9 48.2%   
Avg P/E ratio x-65.331.4 -208.2%  
P/CF ratio (eoy) x39.916.6 240.2%  
Price / Book Value ratio x0.63.1 20.4%  
Dividend payout %-110.216.2 -680.3%   
Avg Mkt Cap Rs m16,680468,031 3.6%   
No. of employees `0002.622.6 11.5%   
Total wages/salary Rs m2,39328,565 8.4%   
Avg. sales/employee Rs Th4,535.27,053.1 64.3%   
Avg. wages/employee Rs Th919.81,261.5 72.9%   
Avg. net profit/employee Rs Th-98.2659.1 -14.9%   
INCOME DATA
Net Sales Rs m11,801159,710 7.4%  
Other income Rs m9844,766 20.6%   
Total revenues Rs m12,785164,475 7.8%   
Gross profit Rs m-83530,973 -2.7%  
Depreciation Rs m67413,263 5.1%   
Interest Rs m751,684 4.5%   
Profit before tax Rs m-60020,791 -2.9%   
Minority Interest Rs m0-172 0.0%   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3435,695 -6.0%   
Profit after tax Rs m-25614,924 -1.7%  
Gross profit margin %-7.119.4 -36.5%  
Effective tax rate %57.327.4 209.1%   
Net profit margin %-2.29.3 -23.2%  
BALANCE SHEET DATA
Current assets Rs m20,384124,266 16.4%   
Current liabilities Rs m5,02937,715 13.3%   
Net working cap to sales %130.154.2 240.1%  
Current ratio x4.13.3 123.0%  
Inventory Days Days10591 115.6%  
Debtors Days Days13595 142.2%  
Net fixed assets Rs m9,023105,190 8.6%   
Share capital Rs m1411,611 8.7%   
"Free" reserves Rs m26,058148,511 17.5%   
Net worth Rs m26,199150,123 17.5%   
Long term debt Rs m038,301 0.0%   
Total assets Rs m31,496239,633 13.1%  
Interest coverage x-7.013.3 -52.3%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.40.7 56.2%   
Return on assets %-0.66.9 -8.3%  
Return on equity %-1.09.9 -9.8%  
Return on capital %-2.011.8 -16.9%  
Exports to sales %69.434.7 200.0%   
Imports to sales %00-   
Exports (fob) Rs m8,18855,419 14.8%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18857,410 14.3%   
Fx outflow Rs m59619,041 3.1%   
Net fx Rs m7,59238,368 19.8%   
CASH FLOW
From Operations Rs m-3,27816,911 -19.4%  
From Investments Rs m-2,860-16,687 17.1%  
From Financial Activity Rs m-24-3,487 0.7%  
Net Cashflow Rs m-4,690-3,451 135.9%  

Share Holding

Indian Promoters % 50.1 16.0 313.1%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 15.1 12.2 123.8%  
FIIs % 3.0 23.7 12.7%  
ADR/GDR % 0.0 1.1 -  
Free float % 31.7 26.2 121.0%  
Shareholders   20,176 161,166 12.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   VENUS REMEDIES  ORCHID PHARMA LTD  NOVARTIS  TTK HEALTHCARE  SHASUN PHARMA  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (1QFY20); Net Profit Up 5.6% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CIPLA has posted a net profit of Rs 5 bn (up 5.6% YoY). Sales on the other hand came in at Rs 40 bn (up 1.3% YoY). Read on for a complete analysis of CIPLA's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Nov 11, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS